STAA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
STAAR Surgical Co (STAA) is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The lack of clear positive catalysts, weak financial performance, and neutral trading sentiment suggest holding off on purchasing the stock at this time.
The MACD is positive but contracting, RSI is neutral at 53.178, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point of 18.185, with resistance at 19.151 and support at 17.219.
Gross margin increased to 75.68%, up 17.06% YoY, indicating operational efficiency improvements.
Net income dropped significantly by -46.51% YoY, and EPS declined by -46.38% YoY. Analysts have lowered price targets due to uncertainty in the China market and lack of near-term visibility. No recent news or significant insider/hedge fund activity to support bullish sentiment.
In Q4 2025, revenue increased by 18.08% YoY, but net income dropped to -$18.31M, and EPS fell to -$0.37. While gross margin improved, the overall financial performance reflects significant challenges.
Analysts have a Neutral/Hold rating on the stock, with multiple firms lowering price targets. Concerns about the China refractive market and limited near-term visibility are key issues.
